• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • 2026 Election
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
Advertisement
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • Trump Administration
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • 2026 Election
  • Trump Administration
  • IN FOCUS
  • Commentary
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Advertisement
    Home › Authors › Posts by Matthew Perrone

    Matthew Perrone

    Matthew Perrone

    Read the latest stories and analysis from Matthew Perrone.

    FDA reconsiders heart safety of common pain pills Business

    FDA reconsiders heart safety of common pain pills

    Matthew Perrone · February 10, 2014 9:36 pm
    Pharma data play larger role in Olympic drug tests Business

    Pharma data play larger role in Olympic drug tests

    Matthew Perrone · February 7, 2014 11:10 pm
    FDA approves pill camera to screen colon Business

    FDA approves pill camera to screen colon

    Matthew Perrone · February 3, 2014 11:09 pm
    FDA reviews safety of testosterone therapy for men Business

    FDA reviews safety of testosterone therapy for men

    Matthew Perrone · January 31, 2014 11:24 pm
    Advertisement
    FDA: Aleve may be safer on heart than rival drugs Business

    FDA: Aleve may be safer on heart than rival drugs

    Matthew Perrone · January 28, 2014 10:12 pm
    FDA approves diabetes drug with new approach News

    FDA approves diabetes drug with new approach

    Matthew Perrone · January 8, 2014 6:01 pm
    Feds crack down on 4 bogus weight loss aids News

    Feds crack down on 4 bogus weight loss aids

    Matthew Perrone · January 7, 2014 8:40 pm
    New drug approvals from FDA declined in 2013 News

    New drug approvals from FDA declined in 2013

    Matthew Perrone · January 2, 2014 4:05 pm
    Advertisement
    FDA: Anti-bacterial soaps may not curb bacteria News

    FDA: Anti-bacterial soaps may not curb bacteria

    Matthew Perrone · December 16, 2013 11:07 pm
    Female libido drug remains in limbo News

    Female libido drug remains in limbo

    Matthew Perrone · December 11, 2013 7:33 pm
    FDA approves breakthrough hepatitis C drug News

    FDA approves breakthrough hepatitis C drug

    Matthew Perrone · December 6, 2013 10:49 pm
    23andMe faces class action lawsuit in California News

    23andMe faces class action lawsuit in California

    Matthew Perrone · December 3, 2013 10:11 pm
    Advertisement
    • ‹Previous page
    • 1
    • …
    • 4
    • 5
    • 6
    • 7
    • 8
    • …
    • 13
    • ›Next page
    Page 6 of 13
    Advertisement
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter
    • © Copyright 2026. Washington Examiner. All Rights Reserved.